Global Healthcare CMO

Healthcare CMO Comprehensive Study by Type (Pharmaceutical CMOS, Medical Device CMOS, Final Goods Assembly), Application (Medical, Healthcare, Others), Medical Device Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products)), Pharmaceutical Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, Packaging) Players and Region - Global Market Outlook to 2030

Healthcare CMO Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Healthcare CMO Market Scope
Contract manufacturing is a kind of outsourcing in which a particular firm contacts with another third party for the purpose of manufacturing the components of its product or the whole of its product. A contract manufacturing organization (CMO) undertakes the production of various products under the brand name of any other firm. An enormous or mid-sized firm opts for a CMO primarily for two reasons, either it wants to shift or lessen its cost and pay emphasis to its core activities, or the manufacturing of its products hereby requires some special or expert handling. CMOS henceforth provide an independent manufacturing service in the healthcare sector also. Healthcare CMOs can hereby be segmented mainly into pharmaceutical and medical device CMOS. After the unearthing of the chemical formula of a new drug, the pharmaceutical CMOs are thereby given the task of further manufacturing it into a whole product, in order for the pharmaceutical companies to sell it into the market under their own brand name. The services that are offered by the pharmaceutical CMOs can further be divided into two main activities namely primary and secondary manufacturing. Contract manufacturing for the medical devices is one of the fastest-growing segments of the entire medical device industry, as all the companies are in the race to bring some new devices to the market. From the past few years, many of the pharmaceutical CMOs have incorporated the development part into their activities, apart from the manufacturing of drugs and they are known as contract development & manufacturing organizations (CDMOs). The market for the pharmaceutical CMOs and CDMOs cannot be taken as the same, nor can it be taken as a completely distinct unit from each other. Furthermore, these two markets can’t be combined together, as they would hereby exaggerate the entire global pharmaceutical CMO market. The global healthcare CMO market has henceforth recorded an unceasing growth since the past few years and is thereby expected to follow the same trend in the upcoming years as well.

According to AMA, the Global Healthcare CMO market is expected to see growth rate of 20.3%

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Healthcare CMO market throughout the predicted period.

Catalent Pharma Solution (United States), Recipharm AB (Sweden), Aurobindo Pharma Limited (India), Symmetry Medical Inc. (United States), Piramal Healthcare (India), Patheon Inc. (United States), Lonza Group AG (Switzerland), Greatbatch Inc. (United States), Fareva (France), DSM (Netherlands) and Boehringer Ingelheim GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Accellent Inc. (United States) and Sanofi (France).

Segmentation Overview
The study have segmented the market of Global Healthcare CMO market by Type (Pharmaceutical CMOS, Medical Device CMOS and Final Goods Assembly), by Application (Medical, Healthcare and Others) and Region with country level break-up.

On the basis of geography, the market of Healthcare CMO has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increased Need for Outsourcing and Approvals of Names

Market Growth Drivers:
A Rise in the Global Pharmaceutical Industry

Challenges:
Availability of Substitutes

Opportunities:
Innovations and Increased Regulatory Pressure on Quality and Less Preference for Outsourcing of Profitable and Biological Drugs by Big Pharmaceutical Companies

Market Leaders and their Expansionary Development Strategies
In January 2024, GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.
In August 2023,Metropolis Healthcare has announced the appointment of Mohan Menon as the new Chief Marketing Officer (CMO). Mohan joins Metropolis with nearly two decades of diverse experience across various sectors and a proven track record of leading and managing successful marketing initiatives, driving revenue growth, and building strong brand equity for global organizations.


Key Target Audience
Providers of Healthcare CMO, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceutical CMOS
  • Medical Device CMOS
  • Final Goods Assembly
By Application
  • Medical
  • Healthcare
  • Others
By Medical Device Services
  • Outsourcing Design
  • Device Manufacturing [Material Process Services, Electronic Manufacturing Services, and Finished Products]

By Pharmaceutical Services
  • Active Pharmaceutical Ingredients (API) Manufacturing
  • Final Dosage Form (FDF) Manufacturing
  • Packaging

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. A Rise in the Global Pharmaceutical Industry
    • 3.3. Market Challenges
      • 3.3.1. Availability of Substitutes
    • 3.4. Market Trends
      • 3.4.1. Increased Need for Outsourcing and Approvals of Names
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare CMO, by Type, Application, Medical Device Services, Pharmaceutical Services and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Healthcare CMO (Value)
      • 5.2.1. Global Healthcare CMO by: Type (Value)
        • 5.2.1.1. Pharmaceutical CMOS
        • 5.2.1.2. Medical Device CMOS
        • 5.2.1.3. Final Goods Assembly
      • 5.2.2. Global Healthcare CMO by: Application (Value)
        • 5.2.2.1. Medical
        • 5.2.2.2. Healthcare
        • 5.2.2.3. Others
      • 5.2.3. Global Healthcare CMO by: Medical Device Services (Value)
        • 5.2.3.1. Outsourcing Design
        • 5.2.3.2. Device Manufacturing [Material Process Services, Electronic Manufacturing Services, and Finished Products]
      • 5.2.4. Global Healthcare CMO by: Pharmaceutical Services (Value)
        • 5.2.4.1. Active Pharmaceutical Ingredients (API) Manufacturing
        • 5.2.4.2. Final Dosage Form (FDF) Manufacturing
        • 5.2.4.3. Packaging
      • 5.2.5. Global Healthcare CMO Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Healthcare CMO: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Catalent Pharma Solution (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Recipharm AB (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aurobindo Pharma Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Symmetry Medical Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Piramal Healthcare (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Patheon Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lonza Group AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Greatbatch Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fareva (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DSM (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Boehringer Ingelheim GmbH (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Healthcare CMO Sale, by Type, Application, Medical Device Services, Pharmaceutical Services and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Healthcare CMO (Value)
      • 7.2.1. Global Healthcare CMO by: Type (Value)
        • 7.2.1.1. Pharmaceutical CMOS
        • 7.2.1.2. Medical Device CMOS
        • 7.2.1.3. Final Goods Assembly
      • 7.2.2. Global Healthcare CMO by: Application (Value)
        • 7.2.2.1. Medical
        • 7.2.2.2. Healthcare
        • 7.2.2.3. Others
      • 7.2.3. Global Healthcare CMO by: Medical Device Services (Value)
        • 7.2.3.1. Outsourcing Design
        • 7.2.3.2. Device Manufacturing [Material Process Services, Electronic Manufacturing Services, and Finished Products]
      • 7.2.4. Global Healthcare CMO by: Pharmaceutical Services (Value)
        • 7.2.4.1. Active Pharmaceutical Ingredients (API) Manufacturing
        • 7.2.4.2. Final Dosage Form (FDF) Manufacturing
        • 7.2.4.3. Packaging
      • 7.2.5. Global Healthcare CMO Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare CMO: by Type(USD Million)
  • Table 2. Healthcare CMO Pharmaceutical CMOS , by Region USD Million (2018-2023)
  • Table 3. Healthcare CMO Medical Device CMOS , by Region USD Million (2018-2023)
  • Table 4. Healthcare CMO Final Goods Assembly , by Region USD Million (2018-2023)
  • Table 5. Healthcare CMO: by Application(USD Million)
  • Table 6. Healthcare CMO Medical , by Region USD Million (2018-2023)
  • Table 7. Healthcare CMO Healthcare , by Region USD Million (2018-2023)
  • Table 8. Healthcare CMO Others , by Region USD Million (2018-2023)
  • Table 9. Healthcare CMO: by Medical Device Services(USD Million)
  • Table 10. Healthcare CMO Outsourcing Design , by Region USD Million (2018-2023)
  • Table 11. Healthcare CMO Device Manufacturing [Material Process Services, Electronic Manufacturing Services, and Finished Products] , by Region USD Million (2018-2023)
  • Table 12. Healthcare CMO: by Pharmaceutical Services(USD Million)
  • Table 13. Healthcare CMO Active Pharmaceutical Ingredients (API) Manufacturing , by Region USD Million (2018-2023)
  • Table 14. Healthcare CMO Final Dosage Form (FDF) Manufacturing , by Region USD Million (2018-2023)
  • Table 15. Healthcare CMO Packaging , by Region USD Million (2018-2023)
  • Table 16. South America Healthcare CMO, by Country USD Million (2018-2023)
  • Table 17. South America Healthcare CMO, by Type USD Million (2018-2023)
  • Table 18. South America Healthcare CMO, by Application USD Million (2018-2023)
  • Table 19. South America Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 20. South America Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 21. Brazil Healthcare CMO, by Type USD Million (2018-2023)
  • Table 22. Brazil Healthcare CMO, by Application USD Million (2018-2023)
  • Table 23. Brazil Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 24. Brazil Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 25. Argentina Healthcare CMO, by Type USD Million (2018-2023)
  • Table 26. Argentina Healthcare CMO, by Application USD Million (2018-2023)
  • Table 27. Argentina Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 28. Argentina Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 29. Rest of South America Healthcare CMO, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Healthcare CMO, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 32. Rest of South America Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 33. Asia Pacific Healthcare CMO, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Healthcare CMO, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Healthcare CMO, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 37. Asia Pacific Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 38. China Healthcare CMO, by Type USD Million (2018-2023)
  • Table 39. China Healthcare CMO, by Application USD Million (2018-2023)
  • Table 40. China Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 41. China Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 42. Japan Healthcare CMO, by Type USD Million (2018-2023)
  • Table 43. Japan Healthcare CMO, by Application USD Million (2018-2023)
  • Table 44. Japan Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 45. Japan Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 46. India Healthcare CMO, by Type USD Million (2018-2023)
  • Table 47. India Healthcare CMO, by Application USD Million (2018-2023)
  • Table 48. India Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 49. India Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 50. South Korea Healthcare CMO, by Type USD Million (2018-2023)
  • Table 51. South Korea Healthcare CMO, by Application USD Million (2018-2023)
  • Table 52. South Korea Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 53. South Korea Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 54. Taiwan Healthcare CMO, by Type USD Million (2018-2023)
  • Table 55. Taiwan Healthcare CMO, by Application USD Million (2018-2023)
  • Table 56. Taiwan Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 57. Taiwan Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 58. Australia Healthcare CMO, by Type USD Million (2018-2023)
  • Table 59. Australia Healthcare CMO, by Application USD Million (2018-2023)
  • Table 60. Australia Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 61. Australia Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Healthcare CMO, by Type USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Healthcare CMO, by Application USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 66. Europe Healthcare CMO, by Country USD Million (2018-2023)
  • Table 67. Europe Healthcare CMO, by Type USD Million (2018-2023)
  • Table 68. Europe Healthcare CMO, by Application USD Million (2018-2023)
  • Table 69. Europe Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 70. Europe Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 71. Germany Healthcare CMO, by Type USD Million (2018-2023)
  • Table 72. Germany Healthcare CMO, by Application USD Million (2018-2023)
  • Table 73. Germany Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 74. Germany Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 75. France Healthcare CMO, by Type USD Million (2018-2023)
  • Table 76. France Healthcare CMO, by Application USD Million (2018-2023)
  • Table 77. France Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 78. France Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 79. Italy Healthcare CMO, by Type USD Million (2018-2023)
  • Table 80. Italy Healthcare CMO, by Application USD Million (2018-2023)
  • Table 81. Italy Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 82. Italy Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 83. United Kingdom Healthcare CMO, by Type USD Million (2018-2023)
  • Table 84. United Kingdom Healthcare CMO, by Application USD Million (2018-2023)
  • Table 85. United Kingdom Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 86. United Kingdom Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 87. Netherlands Healthcare CMO, by Type USD Million (2018-2023)
  • Table 88. Netherlands Healthcare CMO, by Application USD Million (2018-2023)
  • Table 89. Netherlands Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 90. Netherlands Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 91. Rest of Europe Healthcare CMO, by Type USD Million (2018-2023)
  • Table 92. Rest of Europe Healthcare CMO, by Application USD Million (2018-2023)
  • Table 93. Rest of Europe Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 94. Rest of Europe Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 95. MEA Healthcare CMO, by Country USD Million (2018-2023)
  • Table 96. MEA Healthcare CMO, by Type USD Million (2018-2023)
  • Table 97. MEA Healthcare CMO, by Application USD Million (2018-2023)
  • Table 98. MEA Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 99. MEA Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 100. Middle East Healthcare CMO, by Type USD Million (2018-2023)
  • Table 101. Middle East Healthcare CMO, by Application USD Million (2018-2023)
  • Table 102. Middle East Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 103. Middle East Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 104. Africa Healthcare CMO, by Type USD Million (2018-2023)
  • Table 105. Africa Healthcare CMO, by Application USD Million (2018-2023)
  • Table 106. Africa Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 107. Africa Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 108. North America Healthcare CMO, by Country USD Million (2018-2023)
  • Table 109. North America Healthcare CMO, by Type USD Million (2018-2023)
  • Table 110. North America Healthcare CMO, by Application USD Million (2018-2023)
  • Table 111. North America Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 112. North America Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 113. United States Healthcare CMO, by Type USD Million (2018-2023)
  • Table 114. United States Healthcare CMO, by Application USD Million (2018-2023)
  • Table 115. United States Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 116. United States Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 117. Canada Healthcare CMO, by Type USD Million (2018-2023)
  • Table 118. Canada Healthcare CMO, by Application USD Million (2018-2023)
  • Table 119. Canada Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 120. Canada Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 121. Mexico Healthcare CMO, by Type USD Million (2018-2023)
  • Table 122. Mexico Healthcare CMO, by Application USD Million (2018-2023)
  • Table 123. Mexico Healthcare CMO, by Medical Device Services USD Million (2018-2023)
  • Table 124. Mexico Healthcare CMO, by Pharmaceutical Services USD Million (2018-2023)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Healthcare CMO: by Type(USD Million)
  • Table 137. Healthcare CMO Pharmaceutical CMOS , by Region USD Million (2025-2030)
  • Table 138. Healthcare CMO Medical Device CMOS , by Region USD Million (2025-2030)
  • Table 139. Healthcare CMO Final Goods Assembly , by Region USD Million (2025-2030)
  • Table 140. Healthcare CMO: by Application(USD Million)
  • Table 141. Healthcare CMO Medical , by Region USD Million (2025-2030)
  • Table 142. Healthcare CMO Healthcare , by Region USD Million (2025-2030)
  • Table 143. Healthcare CMO Others , by Region USD Million (2025-2030)
  • Table 144. Healthcare CMO: by Medical Device Services(USD Million)
  • Table 145. Healthcare CMO Outsourcing Design , by Region USD Million (2025-2030)
  • Table 146. Healthcare CMO Device Manufacturing [Material Process Services, Electronic Manufacturing Services, and Finished Products] , by Region USD Million (2025-2030)
  • Table 147. Healthcare CMO: by Pharmaceutical Services(USD Million)
  • Table 148. Healthcare CMO Active Pharmaceutical Ingredients (API) Manufacturing , by Region USD Million (2025-2030)
  • Table 149. Healthcare CMO Final Dosage Form (FDF) Manufacturing , by Region USD Million (2025-2030)
  • Table 150. Healthcare CMO Packaging , by Region USD Million (2025-2030)
  • Table 151. South America Healthcare CMO, by Country USD Million (2025-2030)
  • Table 152. South America Healthcare CMO, by Type USD Million (2025-2030)
  • Table 153. South America Healthcare CMO, by Application USD Million (2025-2030)
  • Table 154. South America Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 155. South America Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 156. Brazil Healthcare CMO, by Type USD Million (2025-2030)
  • Table 157. Brazil Healthcare CMO, by Application USD Million (2025-2030)
  • Table 158. Brazil Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 159. Brazil Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 160. Argentina Healthcare CMO, by Type USD Million (2025-2030)
  • Table 161. Argentina Healthcare CMO, by Application USD Million (2025-2030)
  • Table 162. Argentina Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 163. Argentina Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 164. Rest of South America Healthcare CMO, by Type USD Million (2025-2030)
  • Table 165. Rest of South America Healthcare CMO, by Application USD Million (2025-2030)
  • Table 166. Rest of South America Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 167. Rest of South America Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 168. Asia Pacific Healthcare CMO, by Country USD Million (2025-2030)
  • Table 169. Asia Pacific Healthcare CMO, by Type USD Million (2025-2030)
  • Table 170. Asia Pacific Healthcare CMO, by Application USD Million (2025-2030)
  • Table 171. Asia Pacific Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 172. Asia Pacific Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 173. China Healthcare CMO, by Type USD Million (2025-2030)
  • Table 174. China Healthcare CMO, by Application USD Million (2025-2030)
  • Table 175. China Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 176. China Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 177. Japan Healthcare CMO, by Type USD Million (2025-2030)
  • Table 178. Japan Healthcare CMO, by Application USD Million (2025-2030)
  • Table 179. Japan Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 180. Japan Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 181. India Healthcare CMO, by Type USD Million (2025-2030)
  • Table 182. India Healthcare CMO, by Application USD Million (2025-2030)
  • Table 183. India Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 184. India Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 185. South Korea Healthcare CMO, by Type USD Million (2025-2030)
  • Table 186. South Korea Healthcare CMO, by Application USD Million (2025-2030)
  • Table 187. South Korea Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 188. South Korea Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 189. Taiwan Healthcare CMO, by Type USD Million (2025-2030)
  • Table 190. Taiwan Healthcare CMO, by Application USD Million (2025-2030)
  • Table 191. Taiwan Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 192. Taiwan Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 193. Australia Healthcare CMO, by Type USD Million (2025-2030)
  • Table 194. Australia Healthcare CMO, by Application USD Million (2025-2030)
  • Table 195. Australia Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 196. Australia Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 197. Rest of Asia-Pacific Healthcare CMO, by Type USD Million (2025-2030)
  • Table 198. Rest of Asia-Pacific Healthcare CMO, by Application USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 201. Europe Healthcare CMO, by Country USD Million (2025-2030)
  • Table 202. Europe Healthcare CMO, by Type USD Million (2025-2030)
  • Table 203. Europe Healthcare CMO, by Application USD Million (2025-2030)
  • Table 204. Europe Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 205. Europe Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 206. Germany Healthcare CMO, by Type USD Million (2025-2030)
  • Table 207. Germany Healthcare CMO, by Application USD Million (2025-2030)
  • Table 208. Germany Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 209. Germany Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 210. France Healthcare CMO, by Type USD Million (2025-2030)
  • Table 211. France Healthcare CMO, by Application USD Million (2025-2030)
  • Table 212. France Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 213. France Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 214. Italy Healthcare CMO, by Type USD Million (2025-2030)
  • Table 215. Italy Healthcare CMO, by Application USD Million (2025-2030)
  • Table 216. Italy Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 217. Italy Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 218. United Kingdom Healthcare CMO, by Type USD Million (2025-2030)
  • Table 219. United Kingdom Healthcare CMO, by Application USD Million (2025-2030)
  • Table 220. United Kingdom Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 221. United Kingdom Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 222. Netherlands Healthcare CMO, by Type USD Million (2025-2030)
  • Table 223. Netherlands Healthcare CMO, by Application USD Million (2025-2030)
  • Table 224. Netherlands Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 225. Netherlands Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 226. Rest of Europe Healthcare CMO, by Type USD Million (2025-2030)
  • Table 227. Rest of Europe Healthcare CMO, by Application USD Million (2025-2030)
  • Table 228. Rest of Europe Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 229. Rest of Europe Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 230. MEA Healthcare CMO, by Country USD Million (2025-2030)
  • Table 231. MEA Healthcare CMO, by Type USD Million (2025-2030)
  • Table 232. MEA Healthcare CMO, by Application USD Million (2025-2030)
  • Table 233. MEA Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 234. MEA Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 235. Middle East Healthcare CMO, by Type USD Million (2025-2030)
  • Table 236. Middle East Healthcare CMO, by Application USD Million (2025-2030)
  • Table 237. Middle East Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 238. Middle East Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 239. Africa Healthcare CMO, by Type USD Million (2025-2030)
  • Table 240. Africa Healthcare CMO, by Application USD Million (2025-2030)
  • Table 241. Africa Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 242. Africa Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 243. North America Healthcare CMO, by Country USD Million (2025-2030)
  • Table 244. North America Healthcare CMO, by Type USD Million (2025-2030)
  • Table 245. North America Healthcare CMO, by Application USD Million (2025-2030)
  • Table 246. North America Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 247. North America Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 248. United States Healthcare CMO, by Type USD Million (2025-2030)
  • Table 249. United States Healthcare CMO, by Application USD Million (2025-2030)
  • Table 250. United States Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 251. United States Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 252. Canada Healthcare CMO, by Type USD Million (2025-2030)
  • Table 253. Canada Healthcare CMO, by Application USD Million (2025-2030)
  • Table 254. Canada Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 255. Canada Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 256. Mexico Healthcare CMO, by Type USD Million (2025-2030)
  • Table 257. Mexico Healthcare CMO, by Application USD Million (2025-2030)
  • Table 258. Mexico Healthcare CMO, by Medical Device Services USD Million (2025-2030)
  • Table 259. Mexico Healthcare CMO, by Pharmaceutical Services USD Million (2025-2030)
  • Table 260. Research Programs/Design for This Report
  • Table 261. Key Data Information from Secondary Sources
  • Table 262. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare CMO: by Type USD Million (2018-2023)
  • Figure 5. Global Healthcare CMO: by Application USD Million (2018-2023)
  • Figure 6. Global Healthcare CMO: by Medical Device Services USD Million (2018-2023)
  • Figure 7. Global Healthcare CMO: by Pharmaceutical Services USD Million (2018-2023)
  • Figure 8. South America Healthcare CMO Share (%), by Country
  • Figure 9. Asia Pacific Healthcare CMO Share (%), by Country
  • Figure 10. Europe Healthcare CMO Share (%), by Country
  • Figure 11. MEA Healthcare CMO Share (%), by Country
  • Figure 12. North America Healthcare CMO Share (%), by Country
  • Figure 13. Global Healthcare CMO share by Players 2023 (%)
  • Figure 14. Global Healthcare CMO share by Players (Top 3) 2023(%)
  • Figure 15. Global Healthcare CMO share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Catalent Pharma Solution (United States) Revenue, Net Income and Gross profit
  • Figure 18. Catalent Pharma Solution (United States) Revenue: by Geography 2023
  • Figure 19. Recipharm AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 20. Recipharm AB (Sweden) Revenue: by Geography 2023
  • Figure 21. Aurobindo Pharma Limited (India) Revenue, Net Income and Gross profit
  • Figure 22. Aurobindo Pharma Limited (India) Revenue: by Geography 2023
  • Figure 23. Symmetry Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Symmetry Medical Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Piramal Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 26. Piramal Healthcare (India) Revenue: by Geography 2023
  • Figure 27. Patheon Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Patheon Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Lonza Group AG (Switzerland) Revenue: by Geography 2023
  • Figure 31. Greatbatch Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Greatbatch Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Fareva (France) Revenue, Net Income and Gross profit
  • Figure 34. Fareva (France) Revenue: by Geography 2023
  • Figure 35. DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 36. DSM (Netherlands) Revenue: by Geography 2023
  • Figure 37. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2023
  • Figure 39. Global Healthcare CMO: by Type USD Million (2025-2030)
  • Figure 40. Global Healthcare CMO: by Application USD Million (2025-2030)
  • Figure 41. Global Healthcare CMO: by Medical Device Services USD Million (2025-2030)
  • Figure 42. Global Healthcare CMO: by Pharmaceutical Services USD Million (2025-2030)
  • Figure 43. South America Healthcare CMO Share (%), by Country
  • Figure 44. Asia Pacific Healthcare CMO Share (%), by Country
  • Figure 45. Europe Healthcare CMO Share (%), by Country
  • Figure 46. MEA Healthcare CMO Share (%), by Country
  • Figure 47. North America Healthcare CMO Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Catalent Pharma Solution (United States)
  • Recipharm AB (Sweden)
  • Aurobindo Pharma Limited (India)
  • Symmetry Medical Inc. (United States)
  • Piramal Healthcare (India)
  • Patheon Inc. (United States)
  • Lonza Group AG (Switzerland)
  • Greatbatch Inc. (United States)
  • Fareva (France)
  • DSM (Netherlands)
  • Boehringer Ingelheim GmbH (Germany)
Additional players considered in the study are as follows:
Accellent Inc. (United States) , Sanofi (France)
Select User Access Type

Key Highlights of Report


Mar 2024 217 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare CMO Quantitative research analysis
Global Healthcare CMO Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Healthcare CMO study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Healthcare CMO Market is gaining popularity and expected to see strong valuation by 2030 .
According to AMA, the Global Healthcare CMO market is expected to see growth rate of xx%.
The Healthcare CMO market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Healthcare CMO Report?

Have a Query? Click Here

Other Related Reports

Protein Biochips Comprehensive Study by Type (Analytic Protein Biochips, Functional Protein Biochips, Reverse Phase Protein Biochips), Application (Diagnostics, Proteomics, Protein functional Analysi...
$ 3750
Anti-depressant Drugs Comprehensive Study by Type (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Sero...
$ 3750
Nutraceutical Ingredients Comprehensive Study by Type (Prebiotics, Probiotics, Minerals, Vitamins, Omega-3 fatty acids, Fibers & specialty carbohydrates, Proteins & amino acids, Carotenoids, Phytoche...
$ 3750
Capecitabine Comprehensive Study by Type (500 mg, 150 mg), Application (Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, Others), Drug Formulation (Tablets, Capsule) Players and Region - G...
$ 3500
Antiseptic Mouthwash Comprehensive Study by Type (Natural Mouthwash, Fluoride Mouthwash), Distribution Channel (Hypermarket & Supermarket, Convenience Stores, Online Sale) Players and Region - Global...
$ 3500
Adult Vaccines- Comprehensive Study by Type (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, Others), End Users (Medi...
$ 3750